Search
for
Sort by
Research 91–120 of 1000+
- Dyad of infantile cutaneous and thymic Langerhans cell histiocytosis: Is it rare?
- The Cutaneous Epidermal Growth Factor Network: Can it be Translated Clinically to Stimulate Hair Growth?
- Phase II Evaluation of VDC‐1101 in Canine Cutaneous T‐Cell Lymphoma
- Epidermal Growth Factor Receptor Inhibitors: Cutaneous Side Effects and Their Management.
- Advances in Stem Cell Therapy: Specific Applications in the Treatment of Cutaneous Radiation Syndrome
- Skin changes in pediatric transplant patients
- Successful in situ 5-aminolevulinic acid photodynamic therapy in a 53-year-old female with cutaneous squamous cell carcinoma
- Canine and Feline Cutaneous Lymphocytosis: Reactive Process or Indolent Neoplastic Disease?
- Systems for Mitochondria-Protective Cosmetic Actives: Opportunities in Post-Oncologic Skin Regeneration
- When Rare Meets Risky: Clouston Syndrome with Cutaneous Squamous Cell Carcinoma
- Cutaneous Manifestations in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED): A Comprehensive Review
- The Cutaneous Epidermal Growth Factor Network: Can it be Translated Clinically to Stimulate Hair Growth? - eScholarship
- Blackness and Philosophy: Reply to Gannett, Outlaw, Taylor, and Velazco y Trianosky
- Cutaneous and Mucosal Lichen Planus: A Comprehensive Review of Clinical Subtypes, Risk Factors, Diagnosis, and Prognosis
- Changing Incidence Trends of Cutaneous B-Cell Lymphoma
- INTERFERONS IN DERMATOLOGY
- Cutaneous Lesions in the Rat Following Administration of an Irreversible Inhibitor of erbB Receptors, Including the Epidermal Growth Factor Receptor
- Uncovering the complex relationship between balding, testosterone and skin cancers in men
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Multiple minute digitate hyperkeratosis
- Women's Skin throughout Lifetime
- MmuPV1-Induced Cutaneous Squamous Cell Carcinoma Arises Preferentially from Lgr5+ Epithelial Progenitor Cells
- Dermatologic Care of the Transplant Patient
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- Cutaneous manifestations in patients attending the hematology clinic at King Fahd Hospital of the University during a 13 week-period
- Chemotherapy and Cutaneous Drug Reactions
- Cutaneous Sequelae After Burn Injury: Pruritus, Dyspigmentation and Malignancy—Mechanisms and Management
- Chemotherapy‐induced alopecia: an exploratory questionnaire‐based study from Israel comparing knowledge, attitudes, and management practices among dermatologists and oncologists
- Grand challenges in dermatologic drug discovery: four priorities to transform skin disease treatment
- Dissecting the Impact of α-MSH-MC1R-cAMP Signaling on UVA-Induced Stress in Fibroblasts - Implications for Regulation of Cutaneous Photoaging